ALT pathway activity is most frequently seen in cancers of mesenchymal origin (such as osteosarcoma, soft tissue sarcoma) and central nervous system or neural crest malignancies (such as glioblastoma and neuroblastoma) and, as such, is particularly relevant to cancers affecting children, teenagers and young adults [1, 2]. This evidence concerns the gene GPT and neuroblastoma.